Biotech

All Articles

Ideaya bags possibility on Biocytogen bispecific ADC in $400M offer

.Ideaya Biosciences is betting $400 thousand in biobucks that a bispecific antibody-drug conjugate (...

Takeda takes $140M reduction on fallen short epilepsy medication, proclaims FDA run

.Our team actually recognize that Takeda is planning to discover a road to the FDA for epilepsy medi...

VBI Injections declare insolvency, looks for property purchase

.Immunology biotech VBI Vaccinations is actually diverting hazardously near to the point of no retur...

Celldex anti-cKIT antibody lessen colonies in another stage 2 study

.It's not easy to muscle mass in on a space as affordable as immunology, however Celldex Therapeutic...

Boehringer provides to $1.3 B for gate prevention biotech

.Boehringer Ingelheim is offering up to $1.3 billion for Nerio Therapies and also a preclinical immu...

Ventyx's last resort for inflamed med sides in Crohn's failure

.Ventyx Biosciences' Crohn's condition medicine performed not aid clients accomplish remission in a ...

Cognition's phase 2 beam information stain Alzheimer's possibility

.Knowledge Rehabs' stage 2 sparkle trial has taken a few of the radiance off the Alzheimer's disease...

BMS axes bispecific months after filing to function stage 3 trial

.Bristol Myers Squibb has had a whiplash change of heart on its own BCMA bispecific T-cell engager, ...

Charles Baum takes control of Terremoto as CEO

.Charles Baum, M.D., Ph.D., who supervised Mirati Therapies' $ 5.8 billion purchase to Bristol Myers...

Asarina to shut after initiatives to companion Tourette's medicine neglect

.After connecting to greater than 200 companies to partner a Tourette disorder therapy that presente...